Manuel Z. A.
- Country
- Spain
- Department
- Oncology
Research Overview
- Phase Ib/II Study of Bexmarilimab Plus Doxorubicin for Safety and Efficacy in Adults with Metastatic Soft‑Tissue Sarcoma
- Evaluation of EIK1001 and Pembrolizumab Versus Placebo and Pembrolizumab in Advanced Melanoma: A Randomized, Double-Blind, Phase 2/3 Study
- Phase 1 Study of GEN1046 in Combination with Paclitaxel Albumin-Bound, Cisplatin, and Pembrolizumab in Malignant Solid Tumors
Data & Insights
Has run more than one trial at 12 of 119 partner sites.
Specializations
Melanoma Research
This investigator specializes in the treatment of advanced melanoma and post-surgical melanoma management, with particular focus on patients with varying disease stages including Stage IIB, IIC, and III melanoma.
- Advanced Melanoma Treatment
- Post-Surgical Therapy
- Stage-Specific Interventions
The investigator's work encompasses both early-stage resected melanoma and advanced disease states.
Immunotherapy Applications
The investigator focuses on immunotherapeutic approaches in melanoma treatment, particularly exploring novel combination therapies and treatment optimization strategies.
- First-Line Therapy Development
- Combination Treatment Approaches
- Therapeutic Response Assessment
Their research examines innovative therapeutic combinations for improving patient outcomes in melanoma treatment.
Clinical Assessment
The investigator's expertise includes evaluation of treatment efficacy and safety profiles in melanoma therapeutics, utilizing advanced assessment methodologies.
- Treatment Response Monitoring
- Safety Assessment
- Comparative Therapeutic Analysis
Their work incorporates comprehensive evaluation of therapeutic interventions in various melanoma treatment settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.